radiolabeled onartuzumab (Genentech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameradiolabeled onartuzumab (Genentech)
Drug Alias Name76Br-MetMab76Br-onartuzumab89Zr-Df-MetMab89Zr-Df-onartuzumab89Zr-labeled MetMab (Genentech) +[13] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedRadiation-emitting products
Mechanisms of ActionHepatocyte growth factor receptor modulators
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenentech Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A